New schizophrenia drug aims to fix the 'Thinking Problem' current meds miss

NCT ID NCT07084831

Summary

This study is testing whether a newer schizophrenia medication called Xanomeline/Trospium (XT) can improve thinking, memory, and concentration over one year of treatment. It involves 171 adults with schizophrenia who are already stable on their current antipsychotic medication. The main goal is to see if XT can help with the cognitive symptoms that standard treatments often don't address, which could lead to better daily functioning and quality of life.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COGNITIVE IMPAIRMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • AOU Città della Salute e della Scienza di Torino

    NOT_YET_RECRUITING

    Torino, 10126, Italy

    Contact Email: •••••@•••••

  • Central Institute of Mental Health

    NOT_YET_RECRUITING

    Mannheim, 68159, Germany

    Contact Email: •••••@•••••

  • Hospital Clínic de Barcelona

    NOT_YET_RECRUITING

    Barcelona, 08036, Spain

    Contact Email: •••••@•••••

  • Hospital Universitario La Paz

    NOT_YET_RECRUITING

    Madrid, 28046, Spain

    Contact Email: •••••@•••••

  • Hospital Universitario Virgen del Rocío

    NOT_YET_RECRUITING

    Seville, 41013, Spain

    Contact Email: •••••@•••••

  • Ludwig Maximilian University

    NOT_YET_RECRUITING

    München, 80336, Germany

    Contact Email: •••••@•••••

  • Medical University Innsbruck

    NOT_YET_RECRUITING

    Innsbruck, 6020, Austria

    Contact Email: •••••@•••••

  • National Institute of Mental Health

    NOT_YET_RECRUITING

    Klecany, 250 67, Czechia

    Contact Email: •••••@•••••

  • Psykiatrisk Center Glostrup

    NOT_YET_RECRUITING

    Glostrup Municipality, 2600, Denmark

    Contact Email: •••••@•••••

  • Semmelweis University

    NOT_YET_RECRUITING

    Budapest, 1083, Hungary

    Contact Email: •••••@•••••

  • Sheba Medical Center

    RECRUITING

    Ramat Gan, Israel

    Contact Email: •••••@•••••

  • UPC KU Leuven

    NOT_YET_RECRUITING

    Leuven, 3070, Belgium

    Contact Email: •••••@•••••

  • University Hospital Cologne

    NOT_YET_RECRUITING

    Cologne, 50937, Germany

    Contact Email: •••••@•••••

  • University Medical Center Groningen

    NOT_YET_RECRUITING

    Groningen, Netherlands

    Contact Email: •••••@•••••

  • University of Augsburg

    NOT_YET_RECRUITING

    Augsburg, 86156, Germany

    Contact Email: •••••@•••••

  • University of Campania Luigi Vanvitelli

    NOT_YET_RECRUITING

    Naples, 80138, Italy

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.